KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hologic (HOLX) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Hologic (HOLX) over the last 17 years, with Q4 2025 value amounting to -$18.0 million.

  • Hologic's Change in Receivables fell 14316.55% to -$18.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$67.5 million, marking a year-over-year decrease of 8000.0%. This contributed to the annual value of -$7.8 million for FY2025, which is 8097.56% up from last year.
  • Latest data reveals that Hologic reported Change in Receivables of -$18.0 million as of Q4 2025, which was down 14316.55% from -$4.6 million recorded in Q3 2025.
  • Hologic's Change in Receivables' 5-year high stood at $48.1 million during Q4 2021, with a 5-year trough of -$282.9 million in Q2 2021.
  • In the last 5 years, Hologic's Change in Receivables had a median value of -$17.8 million in 2024 and averaged -$31.2 million.
  • In the last 5 years, Hologic's Change in Receivables plummeted by 1316666.67% in 2022 and then skyrocketed by 12458.25% in 2023.
  • Hologic's Change in Receivables (Quarter) stood at $48.1 million in 2021, then decreased by 6.44% to $45.0 million in 2022, then fell by 15.11% to $38.2 million in 2023, then grew by 9.16% to $41.7 million in 2024, then plummeted by 143.17% to -$18.0 million in 2025.
  • Its Change in Receivables stands at -$18.0 million for Q4 2025, versus -$4.6 million for Q3 2025 and -$48.6 million for Q2 2025.